6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (IWADRLH) 26-28 October 2004, Washington
31 January 2005. Related: Conference reports.
Lipodystrophy Workshop (IWADRW) 6th Washington 2004
Nucleoside analogue-related mitochondrial toxicity and link to lipoatrophy: effect of non-thymidine analogues abacavir and tenofovir
31 January 2005. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Nucleosides reduce PPAR-gamma: a role for rosiglitazone without thymidine analogues?
31 January 2005. Related: Conference reports.
Potential for uridine to treat mitochondrial toxicity: still only in vitro data
31 January 2005. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
25% patients take Kaletra on an empty stomach: dietary advice often missed at ‘centre of excellence’
31 January 2005. Related: Conference reports, Antiretrovirals.
rHGH reduces central fat accumulation in adolescent lipodystrophy
31 January 2005. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Weight loss is associated with elevated PBMC proviral DNA levels
31 January 2005. Related: Conference reports, Basic science and immunology.
Coronary artery bypass graft is safe in HIV-positive patients but shows higher risk of longer term events
31 January 2005. Related: Conference reports, Other news.
Endothelial dysfunction similar in ARV-experienced and -naive patients
31 January 2005. Related: Conference reports, Side effects.
Pravastatin improves lipid profiles but not endothelial function
31 January 2005. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Indinavir impairs endothelial function without insulin resistance
31 January 2005. Related: Conference reports, Antiretrovirals.
Treatment interruptions improve lipids within four weeks: IL-2 has no metabolic effect
31 January 2005. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Improvement of lipids following switch to tenofovir
31 January 2005. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
HCV coinfection linked to discontinuing ART due to toxicity
31 January 2005. Related: Conference reports, Hepatitis coinfection.
Restorative treatments for HIV-associated lipoatrophy
31 January 2005. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.